These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3310323)

  • 1. Effect of prostacyclin derivatives on platelet factor 3 availability.
    Skopál J; Kovács M; Stadler I; Galambos G; Kovács G
    Thromb Res; 1987 Jul; 47(1):117-21. PubMed ID: 3310323
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of platelet factor 3 availability by prostacyclin.
    Hársfalvi J; Muszbek L; Stadler I; Fésüs L
    Prostaglandins; 1980 Nov; 20(5):935-45. PubMed ID: 7008092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prostacyclin analogues on platelet aggregation and blood pressure of anaesthetized beagle dogs.
    Hermán F; Hadházy P; Magyar K; Kovács G
    Prog Clin Biol Res; 1987; 242():101-6. PubMed ID: 3313407
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of mithramycin on some platelet functions in vitro.
    Kubisz P; Klener P; Cronberg S
    Acta Haematol; 1980; 63(2):101-6. PubMed ID: 6445152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human platelet activation by an alkylacetyl analogue of phosphatidylcholine.
    Rao GH; Schmid HH; Reddy KR; White JG
    Biochim Biophys Acta; 1982 Apr; 715(2):205-14. PubMed ID: 6280777
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Platelet membrane alterations following collagen stimulation.
    Webber AJ; Bennett EA; Booth W
    Thromb Diath Haemorrh; 1975 Nov; 34(2):575. PubMed ID: 1198471
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergic effect of cicaprost-clathrate and low-dose acetylsalicylic acid on platelet aggregation in man.
    Mahler M; Seifert W; Spiegel B; Staks T
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):446-7. PubMed ID: 1490775
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative insensitivity of epinephrine induced platelet aggregation to prostacyclin.
    Zahavi M; Zahavi J
    Thromb Res; 1986 Oct; 44(1):119-24. PubMed ID: 3538494
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of low concentrations of prostacyclin on platelet function in vitro.
    van Heerden PV; Gibbs NM; Michalopoulos N
    Anaesth Intensive Care; 1997 Aug; 25(4):343-6. PubMed ID: 9288373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
    Maurin N
    Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
    Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
    Michel G; Seipp U
    Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cicaprost inhibits collagen-induced platelet accumulation in rat lungs for some hours.
    Nowak G; Bucha E
    Agents Actions Suppl; 1995; 45():101-6. PubMed ID: 7536381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood.
    Saniabadi AR; Lowe GD; Belch JJ; Forbes CD; Prentice CR; Barbenel JC
    Thromb Haemost; 1983 Oct; 50(3):718-21. PubMed ID: 6196854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of human plasma lipoproteins on platelet aggregation and platelet factor 3 activity in vitro.
    Miller NE; Nordoy A
    Atherosclerosis; 1977 Oct; 28(2):181-6. PubMed ID: 199206
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
    Ubatuba FB; Moncada S; Vane JR
    Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different requirements for intrinsic factor-Xa forming activity and platelet factor 3 activity and their relationship to platelet aggregation and secretion.
    Walsh PN; Camp E; Dende D
    Br J Haematol; 1978 Oct; 40(2):311-31. PubMed ID: 708650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.